These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 15628799)

  • 21. Randomized comparison of piperacillin-tazobactam plus amikacin versus cefoperazone-sulbactam plus amikacin for management of febrile neutropenia in children with lymphoma and solid tumors.
    Demirkaya M; Celebi S; Sevinir B; Hacımustafaoglu M
    Pediatr Hematol Oncol; 2013 Mar; 30(2):141-8. PubMed ID: 23301757
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative in-vitro activity of cefoperazone-tazobactam and cefoperazone-sulbactam combinations against ESBL pathogens in respiratory and urinary infections.
    Patankar M; Sukumaran S; Chhibba A; Nayak U; Sequeira L
    J Assoc Physicians India; 2012 Nov; 60():22-4. PubMed ID: 23767198
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Cefoperazone-sulbactam plus minocycline in the treatment of extensively drug resistant Acinetobacter infections].
    Shi Y; Xu YC; Liu Y; Du W; Rui X; Wang Y
    Zhonghua Yi Xue Za Zhi; 2012 Oct; 92(40):2847-50. PubMed ID: 23290215
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A retrospective analysis of carbapenem-resistant Acinetobacter baumannii-mediated nosocomial pneumonia and the in vitro therapeutic benefit of cefoperazone/sulbactam.
    Xia J; Zhang D; Xu Y; Gong M; Zhou Y; Fang X
    Int J Infect Dis; 2014 Jun; 23():90-3. PubMed ID: 24726664
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sulbactam treatment for pneumonia involving multidrug-resistant Acinetobacter calcoaceticus-Acinetobacter baumannii complex.
    Lin HS; Lee MH; Cheng CW; Hsu PC; Leu HS; Huang CT; Ye JJ
    Infect Dis (Lond); 2015 Jun; 47(6):370-8. PubMed ID: 25746600
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sulbactam/ampicillin combination in the treatment of acute and chronic lower respiratory infections.
    Bisetti A; Grassi L; Scacciacillani E; Putti P
    J Int Med Res; 1991; 19 Suppl 1():36A-43A. PubMed ID: 2060692
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and safety of intravenous sulbactam/ampicillin 3 g 4 times daily in Japanese adults with moderate to severe community-acquired pneumonia: a multicenter, open-label, uncontrolled study.
    Kohno S; Tateda K; Mikamo H; Kadota J; Niki Y; Itamura R
    J Infect Chemother; 2015 Mar; 21(3):182-8. PubMed ID: 25533886
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Comparative in vitro activity of ampicillin, cefoperazone and their combinations with sulbactam, as well as that of other antibiotics against anaerobic organisms].
    Rezvan SP; Sidorenko SV; Budanov SV
    Antibiot Khimioter; 1995 Apr; 40(4):25-9. PubMed ID: 7654095
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Analysis of drug resistance of Pseudomonas aeruginosa and use of antibiotics in burn wards during 6 years].
    Dou Y; Zhang Q
    Zhonghua Shao Shang Za Zhi; 2014 Feb; 30(1):9-14. PubMed ID: 24684983
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Sulbactam in combination with mezlocillin, piperacillin or cefotaxime. Clinical and bacteriological results in the treatment of severe bacterial infections].
    Manncke K; Springsklee M; Heizmann WR; Sonntag HG
    Med Klin (Munich); 1991 Sep; 86(9):454-60. PubMed ID: 1943983
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Laboratory and clinical study of sulbactam/cefoperazone (SBT/CPZ) on bacterial prostatitis].
    Suzuki K; Horiba M
    Hinyokika Kiyo; 1991 Oct; 37(10):1333-43. PubMed ID: 1755429
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular correlation between in vitro and in vivo activity of beta-lactam and beta-lactamase inhibitor combinations against methicillin-resistant Staphylococcus aureus.
    Fasola EL; Fasching CE; Peterson LR
    J Lab Clin Med; 1995 Feb; 125(2):200-11. PubMed ID: 7844469
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Use of a combination of cefoperazone with sulbactam for treatment of patients with wound infections].
    Iakovlev VP; Blatun LA; Puchkova LS; Svetukhin AM
    Antibiot Khimioter; 1994 Dec; 39(12):31-4. PubMed ID: 7733785
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comparison of cefotaxime and cefoperazone in respiratory tract infections.
    Garcia-Rodriguez JA; Gomez-Garcia AC
    J Antimicrob Chemother; 1984 Sep; 14 Suppl B():301-6. PubMed ID: 6094456
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Changes of antimicrobial resistance among nonfermenting gram-negative bacilli isolated from intensive care units from 1994 to 2001 in China].
    Wang H; Chen MJ;
    Zhonghua Yi Xue Za Zhi; 2003 Mar; 83(5):385-90. PubMed ID: 12820914
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In-vitro activity of cefoperazone-sulbactam combination against cefoperazone resistant clinical isolates in a Malaysian general hospital.
    Lim VK; Cheong YM
    Malays J Pathol; 1995 Dec; 17(2):73-6. PubMed ID: 8935129
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cases of Lyme borreliosis resistant to conventional treatment: improved symptoms with cephalosporin plus specific beta-lactamase inhibition.
    Gasser R; Reisinger E; Eber B; Pokan R; Seinost G; Berglöff J; Horwarth R; Sedaj B; Klein W
    Microb Drug Resist; 1995; 1(4):341-4. PubMed ID: 9158807
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of cefoperazone/sulbactam in neonates.
    Ovali F; Gursoy T; Sari I; Divrikli D; Aktas A
    Pediatr Int; 2012 Feb; 54(1):60-3. PubMed ID: 21883691
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [A trial of using sulperazone (cefoperazone/sulbactam) in the combined treatment of patients with a burn infection].
    Iakovlev VP; Krutikov MG; Alekseev AA; Grishina IA; Izotova GN; Kashin IuD
    Antibiot Khimioter; 1995 May; 40(5):38-41. PubMed ID: 8534180
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [A randomized controlled clinical trial of sulperazon in the treatment of surgical infection].
    Tian Y; Zheng X; Xu Y
    Zhonghua Wai Ke Za Zhi; 1996 Dec; 34(12):740-3. PubMed ID: 9590776
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.